Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amanda De Freitas Insider Profile
4 Followers
Amanda De Freitas, Director at Xtacy Therapeutics, holds 98.50K shares in Xtacy Therapeutics (Ticker: XTCYF). Most recently, Amanda De Freitas ― shares of Xtacy Therapeutics on ― for an estimated value of ―.
Amanda De Freitas has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Amanda De Freitas's holdings
Insider Roles
Director
Roles that Amanda De Freitas holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Amanda De Freitas
Amanda De Freitas's Trading History
List of latest transactions for each holding click on a transaction to see Amanda De Freitas's performance on stock
You May Also Like
Amanda De Freitas insider profile FAQ
What is the percentage of profitable transactions made by Amanda De Freitas?
The percentage of profitable transactions made by Amanda De Freitas is ―.
What is the average return per transaction made by Amanda De Freitas?
The average return per transaction made by Amanda De Freitas is ―.
What stocks does Amanda De Freitas hold?
Amanda De Freitas holds: XTCYF stocks.
What was Amanda De Freitas’s latest transaction?
Amanda De Freitas latest transaction was an Uninformative Buy of ―.
What was Amanda De Freitas's most profitable transaction?
Amanda De Freitas’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Amanda De Freitas's role in Xtacy Therapeutics?
Amanda De Freitas's role in Xtacy Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.